Study of Nickel Levels in Patients with Atrial Septal Defect Undergoing Amplatzer Device Closure
| Autor: | Ganesh Narayana, Ganavi Ramagopal, Narender Omprakash Bansal, Bhanu Duggal |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
lcsh:Diseases of the circulatory (Cardiovascular) system Percutaneous business.industry Amplatzer Septal Occluder chemistry.chemical_element 030204 cardiovascular system & hematology Amplatzer device Atrial septal defects Surgery 030207 dermatology & venereal diseases 03 medical and health sciences Nickel nickel 0302 clinical medicine chemistry Nickel titanium lcsh:RC666-701 medicine Device In patient Original Article Defect Prospective cohort study business |
| Zdroj: | Heart Views : The Official Journal of the Gulf Heart Association Heart Views, Vol 19, Iss 3, Pp 85-87 (2018) |
| ISSN: | 1995-705X |
| Popis: | Transcatheter closure of atrial septal defects (ASDs) using nickel titanium Naval Ordnance Laboratory (Nitinol)-containing devices (Amplatzer, AGA Medical, Golden Valley, Minnetosa) is being widely practiced. Controversies still exist regarding the release of nickel from these devices and the allergy and other ill effects of nickel and also the duration of antiplatelet therapy to aid endothelization of the device. Objective: To study the nickel levels in patients who underwent ASD closure with platinum-coated Nitinol-containing Amplatzer septal occluder. Methodology: A prospective study was conducted on 25 patients, between 6 years and 40 years of age who underwent ASD closure with Amplatzer septal occlude sizes ranging from 12 to 36 mm from January 2009 to January 2010. Blood nickel levels were estimated using atomic absorption photometry before and 24 h after the procedure and later at 1 month, 3 months, and 6 months postprocedure. A value of |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|